1-16 of 16
Keywords: Safety
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Eur Neurol (2020) 82 (4-6): 93–98.
Published Online: 08 January 2020
...Guangjian Zhao; Fanzhen Lin; Ziran Wang; Xiaolin Shao; Yanxue Gong; Shirui Zhang; Yansen Cui; Daiqun Yang; Hongyan Lei; Zhongrong Cheng; Liquan Wang; Dongdong Guo; Qinghua Zhang Objective: To verify the efficacy and safety of dual antiplatelet therapy after intravenous thrombolysis for acute minor...
Journal Articles
Eur Neurol (2017) 78 (5-6): 320–329.
Published Online: 26 October 2017
... was change of pain intensity on the 11-point Numerical Rating Scale over a 16-weeks treatment period. Safety was assessed on the basis of adverse reactions (ARs), signs of dependency and abuse. Pain intensity during 16-weeks dronabinol and placebo treatment was reduced by 1.92 and 1.81 points without...
Journal Articles
Eur Neurol (2016) 76 (3-4): 143–150.
Published Online: 02 September 2016
...). Parkinson’s disease Cognition Neuropsychology Safety Longitudinal study Driving Parkinson's disease (PD) is a progressive neurodegenerative disorder that affects the instrumental activities of daily living, including the ability to drive a car [ 1,2,3,4,5 ]. The number of individuals with PD...
Journal Articles
Eur Neurol (2016) 75 (Suppl. 1): 1–3.
Published Online: 23 February 2016
...: A retrospective registry study and a prospective safety study of THC:CBD oromucosal spray are reported. Results: The most recent analysis of a retrospective registry established in the United Kingdom (UK), Germany and Switzerland, which collected safety data on more than 900 patients, has indicated a positive...
Journal Articles
Eur Neurol (2015) 74 (3-4): 127–134.
Published Online: 11 September 2015
... on repeated thrombolysis are limited. Here, we report on the safety and clinical effects of repeated intravenous recombinant tissue-type plasminogen activator (rt-PA) treatment in a large consecutive cohort of stroke patients. Methods: We identified all stroke patients who received repeated thrombolysis. We...
Journal Articles
Eur Neurol (2014) 72 (Suppl. 1): 12–14.
Published Online: 26 September 2014
...Oscar Fernández Background: Clinical trials demonstrate the efficacy and tolerability of an intervention under experimental conditions, but information on use under daily practice conditions is required to confirm the effectiveness and safety of new management options. Summary: Clinical outcomes...
Journal Articles
Eur Neurol (2013) 70 (3-4): 165–171.
Published Online: 06 August 2013
... the effectiveness and safety of MVD in elderly patients with HFS is not clear. Methods: We enrolled 699 HFS patients who underwent MVD from February 2008 to December 2011 at the Samsung Medical Center in Seoul, Korea. Subjects were divided into two groups: an elderly group (patients who were 60 years old or older...
Journal Articles
Journal Articles
Eur Neurol (1994) 34 (Suppl. 2): 40–43.
Published Online: 27 February 2008
...Kate Lloyd The safety and tolerability of sumatriptan have been extensively studied. The majority of adverse events (defined as any medical event irrespective of possible causal relationship to treatment) were mild to moderate in intensity, transient and resolved spontaneously. In short-term...
Journal Articles
Eur Neurol (1996) 36 (Suppl. 2): 24–27.
Published Online: 25 February 2008
...Gilles E.A. Geraud 311C90 is an orally active 5-HT ID agonist with both central and peripheral actions that is currently being developed as an acute antimigraine treatment. Several studies have demonstrated the safety and efficacy of 311C90 in the treatment of a single migraine headache.The...
Journal Articles
Eur Neurol (1996) 36 (Suppl. 2): 19–23.
Published Online: 25 February 2008
... or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods...
Journal Articles
Eur Neurol (1996) 36 (Suppl. 2): 32–33.
Published Online: 25 February 2008
...John G. Edmeads 25 2 2008 311C90 Trigemino-vascular system Efficacy Safety 1996 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means...
Journal Articles
Journal Articles
Eur Neurol (2003) 50 (3): 172–175.
Published Online: 10 October 2003
... or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods...
Journal Articles
Journal Articles